Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esmolol for myocardial protection in breast cancer patients after neoadjuvant chemotherapy
ChiCTR2300072759Phase 4Not yet recruiting
- Sponsor
- Weihai Municipal Hospital
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esmolol in breast cancer (2 arms), sponsored by Weihai Municipal Hospital. Primary endpoints: high-sensitivity cardiac troponin, CK-MB and 2 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
esmolol
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2300072759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072759.